Macter International Limited (PSX: MACTER)

Market Cap	18.41B
Revenue	n/a
Net Income	n/a
Shares Out	45.81M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Oct 16, 2024

Volume	22,653
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	81.50 - 500.34
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 17, 2025

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including sterile liquid vials, sterile liquid ampoules, and sterile ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1992
• Employees: 404
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: MACTER